Ninety One North America’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2017
Q1 | – | Sell |
-24,883
| Closed | -$902K | – | 108 |
|
2016
Q4 | $902K | Sell |
24,883
-217,766
| -90% | -$7.89M | 0.14% | 97 |
|
2016
Q3 | $11.2M | Buy |
242,649
+14,553
| +6% | +$670K | 1.5% | 14 |
|
2016
Q2 | $11.5M | Buy |
228,096
+63,193
| +38% | +$3.17M | 1.69% | 9 |
|
2016
Q1 | $8.82M | Buy |
164,903
+118,425
| +255% | +$6.34M | 1.47% | 29 |
|
2015
Q4 | $3.05M | Buy |
46,478
+31,012
| +201% | +$2.04M | 0.54% | 58 |
|
2015
Q3 | $873K | Buy |
15,466
+3,916
| +34% | +$221K | 0.22% | 75 |
|
2015
Q2 | $683K | Hold |
11,550
| – | – | 0.22% | 74 |
|
2015
Q1 | $720K | Sell |
11,550
-2,580
| -18% | -$161K | 0.22% | 73 |
|
2014
Q4 | $813K | Buy |
+14,130
| New | +$813K | 0.24% | 68 |
|